ALB and pachyonychia congenita: Nanoparticle albumin-bound paclitaxel (nab-PTX) accounts for a major advancement in PC treatment by enhancing drug delivery and tumor penetration while diminishing treatment-emergent adverse events (TEAEs) and toxicities correlated with conventional paclitaxel.